Clifford Swan Investment Counsel LLC Invests $1.34 Million in Marsh & McLennan Companies, Inc. $MRSH

Clifford Swan Investment Counsel LLC bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,225 shares of the financial services provider’s stock, valued at approximately $1,340,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Numerai GP LLC grew its stake in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd lifted its holdings in shares of Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after acquiring an additional 11,648 shares during the period. Rockland Trust Co. lifted its holdings in shares of Marsh & McLennan Companies by 801.6% during the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after acquiring an additional 10,734 shares during the period. Barclays PLC lifted its holdings in shares of Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after acquiring an additional 647,987 shares during the period. Finally, Sarasin & Partners LLP lifted its holdings in shares of Marsh & McLennan Companies by 0.9% during the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after acquiring an additional 8,283 shares during the period. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Trading Up 2.5%

NYSE:MRSH opened at $165.37 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $231.36. The company has a market cap of $79.89 billion, a P/E ratio of 20.67, a price-to-earnings-growth ratio of 2.35 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion for the quarter. The company’s revenue was up 7.6% on a year-over-year basis. As a group, sell-side analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Insider Transactions at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Barclays cut their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Mizuho cut their price target on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a report on Monday, April 13th. Keefe, Bruyette & Woods upped their price target on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a report on Friday, April 17th. Piper Sandler cut their price target on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a report on Tuesday, May 26th. Finally, Morgan Stanley cut their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $203.56.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.